ZA958950B - Treatment of hla-dr associated immunodeficiency with gamma-interferon - Google Patents

Treatment of hla-dr associated immunodeficiency with gamma-interferon

Info

Publication number
ZA958950B
ZA958950B ZA958950A ZA958950A ZA958950B ZA 958950 B ZA958950 B ZA 958950B ZA 958950 A ZA958950 A ZA 958950A ZA 958950 A ZA958950 A ZA 958950A ZA 958950 B ZA958950 B ZA 958950B
Authority
ZA
South Africa
Prior art keywords
hla
interferon
gamma
treatment
associated immunodeficiency
Prior art date
Application number
ZA958950A
Other languages
English (en)
Inventor
Ruediger Baehr
Hans-Dieter Volk
Gerhard G Steinmann
Susanne C Querner
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA958950B publication Critical patent/ZA958950B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA958950A 1994-10-22 1995-10-23 Treatment of hla-dr associated immunodeficiency with gamma-interferon ZA958950B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4437868A DE4437868A1 (de) 1994-10-22 1994-10-22 Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma

Publications (1)

Publication Number Publication Date
ZA958950B true ZA958950B (en) 1996-04-22

Family

ID=6531496

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA958950A ZA958950B (en) 1994-10-22 1995-10-23 Treatment of hla-dr associated immunodeficiency with gamma-interferon

Country Status (5)

Country Link
AU (1) AU5095996A (xx)
CA (1) CA2203255A1 (xx)
DE (1) DE4437868A1 (xx)
WO (1) WO1996012500A1 (xx)
ZA (1) ZA958950B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10218328A1 (de) 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
DE102005053679A1 (de) * 2005-06-24 2006-12-28 Bayer Healthcare Ag Therapeutischer Einsatz von Moxifloxacin zur Rekonstruktion von Funktionsstörungen des Immunsystems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
US5198212A (en) * 1988-10-31 1993-03-30 University Of Lousville Research Foundation Incorporated Method and compositions for treatment of trauma-associated sepsis with gamma interferon

Also Published As

Publication number Publication date
AU5095996A (en) 1996-05-15
WO1996012500A1 (de) 1996-05-02
CA2203255A1 (en) 1996-05-02
DE4437868A1 (de) 1996-04-25

Similar Documents

Publication Publication Date Title
GB9411080D0 (en) Treatment
EP0768038A3 (en) Shortening and its use
ZA953256B (en) Skin treatment composition
EP0811059A4 (en) BETA-11 HUMAN CHEMOKINE AND ALPHA-1 HUMAN CHEMOKINE
HUT77108A (hu) DNS-szekvenciák és alkalmazásuk
GB9203039D0 (en) Treatment
GB9410512D0 (en) Novel treatment
IL115894A0 (en) Organosilanes and organogermanes and their use
GB9222260D0 (en) Skin treatment
GB9405021D0 (en) Skin treatment composition
GB9211736D0 (en) Allergic treatment
EP0465132A3 (en) Dna and its use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
GB2271057B (en) Hair treatment
GB9411635D0 (en) Novel treatment
ZA958950B (en) Treatment of hla-dr associated immunodeficiency with gamma-interferon
GB9415901D0 (en) Novel compounds and treatment
GB9415900D0 (en) Novel compounds and treatment
ZA952120B (en) Skin treatment composition
GB2292219B (en) Polymorphisms in human phosphoglucomutase-1
ZA959512B (en) Aryloxycycloalkenyl and aryloxyiminocycloalkenylhy-droxyureas
GB9218773D0 (en) Skin treatment
GB2296238B (en) Improvements in or relating to effluent treatment
GB9310882D0 (en) Allergic treatment
GB9420243D0 (en) Complex and its use